Variable | Number of studies | Pooled prevalence* | 95% CI | I2 (%) | Heterogeneity (95% CI) | P value | |
---|---|---|---|---|---|---|---|
Subgroup analysis for hepatitis B co-infection among prisoners living with HIV | Â | ||||||
WHO regions | Region of the Americas | 3 | 5 | 3–7 | 0 | 1.75 (-3.37 to 6.87) | 0.48 |
European of region | 11 | 18 | 10–26 | 97.22 | |||
Western Pacific | 2 | 27 | 23–31 | 0 | |||
South-East of Asia | 1 | 3 | 1–11 | 0 | |||
Eastern Mediterranean region | 5 | 3 | 0–5 | 24.16 | |||
African region | 1 | 15 | 8–27 | 0 | |||
Study design | Cross-sectional | 20 | 11 | 6–15 | 96.30 | -6.28 (-33.45 to 20.88) | 0.63 |
Cohort | 3 | 5 | 4–7 | 0 | |||
Quality of study | High | 10 | 8 | 3–13 | 94.02 | -6.36 (-17.83 to 5.09) | 0.26 |
Moderate | 8 | 17 | 5–28 | 96.24 | |||
Low | 5 | 18 | 9–28 | 97.74 | |||
Sample size |  < 50 | 6 | 21 | 0–43 | 96.64 | -10.05 (-30.98 to 10.87) | 0.32 |
 > 50 | 17 | 10 | 7–13 | 95.34 | |||
Year |  < 2005 | 5 | 38 | 16–59 | 99.04 | -8.61 (-15.96 to -1.25) | 0.02 |
2006–2010 | 8 | 6 | 4–8 | 34.60 | |||
2011–2015 | 4 | 3 | 0–6 | 30.21 | |||
 > 2015 | 6 | 5 | 3–8 | 54.80 | |||
Subgroup analysis for Hepatitis C co-infection among prisoners living with HIV | Â | ||||||
WHO regions | Region of the Americas | 17 | 45 | 38–53 | 98.25 | -6.81 (-11.28 to -2.34) | 0.004 |
European of region | 21 | 64 | 50–79 | 99.22 | |||
Western Pacific region | 3 | 75 | 40–100 | 0 | |||
South-East of Asia region | 2 | 83 | 74–91 | 0 | |||
Eastern Mediterranean region | 7 | 83 | 73–93 | 92.69 | |||
Study design | Cross-sectional | 46 | 62 | 52–72 | 99.40 | -6.38 (-37.32 to 24.55) | 0.68 |
Cohort | 4 | 56 | 21–91 | 99.44 | |||
Quality of study | High | 16 | 66 | 55–77 | 97.51 | -2.78 (-14.58 to 9.01) | 0.63 |
Moderate | 24 | 54 | 39–69 | 99.60 | |||
Low | 10 | 75 | 53–96 | 99.48 | |||
Sample size |  < 50 | 17 | 62 | 46–77 | 96.43 | 0.07 (-17.55 to 17.71) | 0.99 |
 > 50 | 33 | 662 | 51–73 | 99.62 | |||
Year |  < 2005 | 11 | 61 | 36–86 | 99.45 | -6.75 (-14.10 to 0.59) | 0.20 |
2006–2010 | 13 | 71 | 53–90 | 99.61 | |||
2011–2015 | 13 | 71 | 56–86 | 97.15 | |||
 > 2015 | 13 | 42 | 25–59 | 99.46 |